Table 3.

Proportion of patients with 30% and 50% reduction in pain at week 4

Response category	Number of patients (%)
	Placebo (n=51)	Fasinumab
		0.1 mg/kg (n=53)	0.3 mg/kg (n=53)
30% reduction in pain
Average leg pain	33 (64.7)	32 (60.4)	33 (62.3)
Worst leg pain	34 (66.7)	33 (62.3)	35 (66.0)
Average back pain	32 (62.7)	28 (52.8)	38 (71.7)
Worst back pain	34 (66.7)	30 (56.6)	37 (69.8)
50% reduction in pain
Average leg pain	28 (54.9)	22 (41.5)	24 (45.3)
Worst leg pain	30 (58.8)	21 (39.6)	26 (49.1)
Average back pain	22 (43.1)	19 (35.8)	26 (49.1)
Worst back pain	19 (37.3)	21 (39.6)	26 (49.1)